市場調査レポート
商品コード
1208352

核酸サンプル調製の世界市場 (2022-2032年):製品・ワークフロー・技術・治療分野・用途・エンドユーザー・地域別の分析・予測

Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Technology, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2022-2032

出版日: | 発行: BIS Research | ページ情報: 英文 240 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
核酸サンプル調製の世界市場 (2022-2032年):製品・ワークフロー・技術・治療分野・用途・エンドユーザー・地域別の分析・予測
出版日: 2023年01月30日
発行: BIS Research
ページ情報: 英文 240 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核酸サンプル調製の市場規模は、2022年の42億1,300万米ドルから、予測期間中は10.27%のCAGRで推移し、2032年には112億50万米ドルの規模に成長すると予測されています。

いくつかの治療領域で核酸分子が使用されるようになったことが同市場の成長の原動力になると予想されています。また、次世代シーケンサー(NGS)などの下流用途の需要の増加や、核酸抽出・分離技術の進歩も同市場の成長を牽引しています。

地域別では、北米地域が2021年に46.99%のシェアで市場を独占し、予測期間を通じてその優位性を維持すると予測されています。一方、予測期間中は、いくつかの新興国を構成するアジア太平洋地域が12.01%のCAGRで最高の成長を記録すると予想されています。

当レポートでは、世界の核酸サンプル調製の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 市場

  • 製品定義
  • 市場範囲
  • 調査手法
  • 市場概要
  • 対応可能な市場規模と成長の可能性
  • 参入事業者の情勢

第2章 世界の核酸サンプル調製市場:産業分析

  • 産業考察
  • 特許分析
  • COVID-19の影響

第3章 世界の核酸サンプル調製市場:市場力学

  • 概要
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第4章 競合情勢

  • 概要
  • 企業戦略
  • 事業戦略
  • 市場シェア分析

第5章 世界の核酸サンプル調製市場:製品別

  • 概要
  • 消耗品
    • サンプル抽出および分離キット
    • サンプル精製キット
    • ライブラリー調製キット
    • クリーンアップおよび選択キット
    • ターゲット濃縮キット
    • マイクロバイオームDNA濃縮
  • システム
    • リキッドハンドリングシステム
    • 核酸抽出/分離システム
    • フラグメントアナライザー
    • その他のサンプル調製システム
  • 付属品・コンポーネント

第6章 世界の核酸サンプル調製市場:ワークフロー別

  • 概要
  • サンプル抽出/分離
  • サンプルの定量化
  • 品質管理(QC)
  • 断片化
  • ターゲットエンリッチメント
  • ライブラリーの定量化
  • プーリング

第7章 世界の核酸サンプル調製市場:技術別

  • 概要
  • スピンカラムベース技術
  • 磁気ビーズベース技術
  • その他

第8章 世界の核酸サンプル調製市場:治療領域別

  • 概要
  • 腫瘍
  • 感染症
  • 人類遺伝学・集団遺伝学
  • その他

第9章 世界の核酸サンプル調製市場:用途別

  • 概要
  • ゲノミクス
  • プロテオミクス
  • その他

第10章 世界の核酸サンプル調製市場:エンドユーザー別

  • 概要
  • 学術研究機関
  • 製薬およびバイオテクノロジー企業
  • 臨床および診断ラボ
  • その他

第11章 世界の核酸サンプル調製市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第12章 企業プロファイル

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • BGI Group(MGI Tech Co., Ltd.)
  • BIONEER CORPORATION.
  • Blue-Ray Biotech Corp.
  • Danaher.(Beckman Coulter, Inc.)
  • Endress+Hauser Group Services AG(Analytik Jena GmbH)
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • Norgen Biotek Corp.
  • OPENTRONS
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN
  • Sansure Biotech Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • 新興企業
図表

List of Figures

  • Figure 1: Global Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
  • Figure 2: Global Nucleic Acid Sample Preparation Market Segmentation
  • Figure 3: Share of Global Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
  • Figure 4: Share of Global Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
  • Figure 5: Share of Global Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
  • Figure 6: Share of Global Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
  • Figure 7: Share of Global Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
  • Figure 8: Share of Global Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
  • Figure 9: Global Nucleic Acid Sample Preparation Market (by Region)
  • Figure 10: Global Nucleic Acid Sample Preparation Market Segmentation
  • Figure 11: Global Nucleic Acid Sample Preparation Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Global Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 16: North America Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 17: Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 18: Asia-Pacific Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 19: Latin America Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 20: Rest-of-the-World Nucleic Acid Sample Preparation Addressable Market, $Million, 2021-2032
  • Figure 21: FDA's Regulatory Insight System
  • Figure 22: Global Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
  • Figure 23: Global Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
  • Figure 24: Global Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
  • Figure 25: Virus Testing Workflow
  • Figure 26: NGS Applications in Laboratories during COVID-19
  • Figure 27: Global Nucleic Acid Sample Preparation Market - Market Dynamics
  • Figure 28: Techniques for Nucleic Acid Extraction/Isolation
  • Figure 29: Benefits of Automated Nucleic Acid Sample Preparation
  • Figure 30: Share of Key Developments, January 2019-November 2022
  • Figure 31: Share of Synergistic Activities (by Company), January 2019-November 2022
  • Figure 32: Number of Business Expansion Activities (by Company), January 2019-November 2022
  • Figure 33: Number of Product Launches (by Company), January 2019-November 2022
  • Figure 34: Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
  • Figure 35: Global Nucleic Acid Sample Preparation Market (by Product)
  • Figure 36: Share of Global Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
  • Figure 37: Global Nucleic Acid Sample Preparation Market (Consumables), $Million, 2021-2032
  • Figure 38: Examples of Sample Extraction and Isolation Kits
  • Figure 39: Examples of Sample Purification Kits
  • Figure 40: Examples of Library Preparation Kits
  • Figure 41: Classification of Library Preparation Kits
  • Figure 42: Examples of Clean-Up and Selection Kits
  • Figure 43: Examples of Target Enrichments Kits
  • Figure 44: Global Nucleic Acid Sample Preparation Market (Systems), $Million, 2021-2032
  • Figure 45: Share of Global Nucleic Acid Sample Preparation Market (by Systems), $Million, 2021-2032
  • Figure 46: Global Nucleic Acid Sample Preparation Market (Liquid Handling Systems), $Million, 2021-2032
  • Figure 47: Examples of Automated Liquid Handling Systems
  • Figure 48: Global Nucleic Acid Sample Preparation Market (Nucleic Acid Extraction/Isolation Systems), $Million, 2021-2032
  • Figure 49: Examples of Nucleic Acid Extraction/Isolation Systems
  • Figure 50: Examples of Fragment Analyzers
  • Figure 51: Global Nucleic Acid Sample Preparation Market (Fragment Analyzers), $Million, 2021-2032
  • Figure 52: Global Nucleic Acid Sample Preparation Market (Other Sample Preparation Systems), $Million, 2021-2032
  • Figure 53: Global Nucleic Acid Sample Preparation Market (Accessories and Components), $Million, 2021-2032
  • Figure 54: Nucleic Acid Sample Preparation Workflow
  • Figure 55: Global Nucleic Acid Sample Preparation Market (by Workflow)
  • Figure 56: Share of Global Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
  • Figure 57: Global Nucleic Acid Sample Preparation Market (Sample Extraction/Isolation), $Million, 2021-2032
  • Figure 58: Global Nucleic Acid Sample Preparation Market (Sample Quantification), $Million, 2021-2032
  • Figure 59: Global Nucleic Acid Sample Preparation Market (Quality Control (QC)), $Million, 2021-2032
  • Figure 60: Global Nucleic Acid Sample Preparation Market (Fragmentation), $Million, 2021-2032
  • Figure 61: Global Nucleic Acid Sample Preparation Market (Target Enrichment), $Million, 2021-2032
  • Figure 62: Global Nucleic Acid Sample Preparation Market (Library Quantification), $Million, 2021-2032
  • Figure 63: Global Nucleic Acid Sample Preparation Market (Pooling), $Million, 2021-2032
  • Figure 64: Share of Global Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
  • Figure 65: Global Nucleic Acid Sample Preparation Market (Spin- Column Based Technology), 2021-2032
  • Figure 66: Global Nucleic Acid Sample Preparation Market (Magnetic-Bead Based Technology), 2021-2032
  • Figure 67: Global Nucleic Acid Sample Preparation Market (Other Technologies), 2021-2032
  • Figure 68: Global Nucleic Acid Sample Preparation Market (by Therapeutic Area)
  • Figure 69: Share of Global Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
  • Figure 70: Global Nucleic Acid Sample Preparation Market (Oncology), $Million, 2021-2032
  • Figure 71: Global Nucleic Acid Sample Preparation Market (Infectious Disease), $Million, 2021-2032
  • Figure 72: Global Nucleic Acid Sample Preparation Market (Human Genetics/Population Genetics), $Million, 2021-2032
  • Figure 73: Global Nucleic Acid Sample Preparation Market (Others), $Million, 2021-2032
  • Figure 74: Global Nucleic Acid Sample Preparation Market (by Application)
  • Figure 75: Share of Global Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
  • Figure 76: Applications of Genomic Technologies
  • Figure 77: Global Nucleic Acid Sample Preparation Market (Genomics), $Million, 2021-2032
  • Figure 78: Applications of Proteomics
  • Figure 79: Global Nucleic Acid Sample Preparation Market (Proteomics), $Million, 2021-2032
  • Figure 80: Global Nucleic Acid Sample Preparation Market (Other Applications), $Million, 2021-2032
  • Figure 81: Global Nucleic Acid Sample Preparation Market (by End User)
  • Figure 82: Share of Global Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
  • Figure 83: Global Nucleic Acid Sample Preparation Market (Academic and Research Institutions), $Million, 2021-2032
  • Figure 84: Global Nucleic Acid Sample Preparation Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
  • Figure 85: Global Nucleic Acid Sample Preparation Market (Clinical and Diagnostic Laboratories), $Million, 2021-2032
  • Figure 86: Global Nucleic Acid Sample Preparation Market (Other End Users), $Million, 2021-2032
  • Figure 87: Global Nucleic Acid Sample Preparation Market (by Region)
  • Figure 88: Global Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
  • Figure 89: North America Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 90: North America Nucleic Acid Sample Preparation Market (by Country), $Million, 2021-2032
  • Figure 91: U.S. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 92: Canada Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 93: Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 94: Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
  • Figure 95: Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 96: France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 97: U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 98: Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 99: Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 100: Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 101: Asia-Pacific Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 102: Asia-Pacific Nucleic Acid Sample Preparation Market (by Country), $Million, 2021-2032
  • Figure 103: China Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 104: Japan Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 105: India Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 106: Australia Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 107: South Korea Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 108: Rest-of-Asia-Pacific Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 109: Latin America Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 110: Latin America Nucleic Acid Sample Preparation Market (by Country), $Million, 2021 and 2032
  • Figure 111: Brazil Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 112: Mexico Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 113: Rest-of-Latin America Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 114: Rest-of-the-World Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 115: Total Number of Companies Profiled
  • Figure 116: Agilent Technologies, Inc.: Product Portfolio
  • Figure 117: Agilent Technologies, Inc.: Overall Financials, $Million, 2019-2021
  • Figure 118: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 119: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 120: Agilent Technologies, Inc: R&D Expenditure, $Million, 2019-2021
  • Figure 121: Aurora Biomed Inc.: Product Portfolio
  • Figure 122: BGI Group (MGI Tech Co., Ltd.): Product Portfolio
  • Figure 123: BIONEER CORPORATION.: Product Portfolio
  • Figure 124: Blue-Ray Biotech Corp.: Product Portfolio
  • Figure 125: Danaher. (Beckman Coulter, Inc.): Product Portfolio
  • Figure 126: Danaher. (Beckman Coulter, Inc.): Overall Financials, $Million, 2019-2021
  • Figure 127: Danaher. (Beckman Coulter, Inc.): Revenue (by Segment), $Million, 2019-2021
  • Figure 128: Danaher. (Beckman Coulter, Inc.): Revenue (by Region), $Million, 2019-2021
  • Figure 129: Danaher. (Beckman Coulter, Inc.): R&D Expenditure, $Million, 2019-2021
  • Figure 130: Endress+Hauser Group Services AG (Analytik Jena GmbH): Product Portfolio
  • Figure 131: Endress+Hauser Group Services AG (Analytik Jena GmbH): Overall Financials, $Million, 2019-2021
  • Figure 132: Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Segment), $Million, 2019-2021
  • Figure 133: Endress+Hauser Group Services AG (Analytik Jena GmbH): R&D Expenditure, $Million, 2019-2021
  • Figure 134: Eppendorf SE: Product Portfolio
  • Figure 135: Eppendorf SE: Overall Financials, $Million, 2019-2021
  • Figure 136: Eppendorf SE: Revenue (by Segment), $Million, 2019-2021
  • Figure 137: Eppendorf SE: Revenue (by Region), $Million, 2019-2021
  • Figure 138: Eppendorf SE: R&D Expenditure, $Million, 2019-2021
  • Figure 139: F. Hoffmann-La Roche Ltd: Product Portfolio
  • Figure 140: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021
  • Figure 141: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021
  • Figure 142: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021
  • Figure 143: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021
  • Figure 144: Illumina, Inc.: Product Portfolio
  • Figure 145: Illumina, Inc.: Overall Financials, $Million, 2019-2021
  • Figure 146: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 147: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 148: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 149: Merck KGaA: Product Portfolio
  • Figure 150: Merck KGaA: Overall Financials, $Million, 2019-2021
  • Figure 151: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
  • Figure 152: Merck KGaA: Revenue (by Region), $Million, 2019-2021
  • Figure 153: Merck KGaA: R&D Expenditure, $Million, 2019-2021
  • Figure 154: Norgen Biotek Corp.: Product Portfolio
  • Figure 155: OPENTRONS: Product Portfolio
  • Figure 156: PerkinElmer Inc.: Product Portfolio
  • Figure 157: PerkinElmer Inc.: Overall Financials, 2019-2021
  • Figure 158: PerkinElmer Inc.: Revenue (by Segment), 2019-2021
  • Figure 159: PerkinElmer Inc.: Revenue (by Region), 2019-2021
  • Figure 160: PerkinElmer Inc.: R&D Expenditure, 2019-2021
  • Figure 161: Promega Corporation: Product Portfolio
  • Figure 162: QIAGEN: Product Portfolio
  • Figure 163: QIAGEN: Overall Financials, 2019-2021
  • Figure 164: QIAGEN: Revenue (by Segment), 2019-2021
  • Figure 165: QIAGEN: Revenue (by Region), 2019-2021
  • Figure 166: QIAGEN: R&D Expenditure, 2019-2021
  • Figure 167: Sansure Biotech Inc.: Product Portfolio
  • Figure 168: Sansure Biotech Inc.: Overall Financials, 2019-2021
  • Figure 169: Sansure Biotech Inc.: R&D Expenditure (Ratio of R&D investment to Revenue (%)), 2019-2021
  • Figure 170: Tecan Trading AG: Product Portfolio
  • Figure 171: Tecan Trading AG: Overall Financials, 2019-2021
  • Figure 172: Tecan Trading AG: Revenue (by Segment), 2019-2021
  • Figure 173: Tecan Trading AG: Revenue (by Region), 2019-2021
  • Figure 174: Tecan Trading AG: R&D Expenditure, 2019-2021
  • Figure 175: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 176: Thermo Fisher Scientific Inc.: Overall Financials, 2019-2021
  • Figure 177: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2019-2021
  • Figure 178: Thermo Fisher Scientific Inc.: Revenue (by Region), 2019-2021
  • Figure 179: Thermo Fisher Scientific Inc.: R&D Expenditure, 2019-2021

List of Tables

  • Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Nucleic Acid Sample Preparation Market
  • Table 2: Industry Participants' Landscape in the Global Nucleic Acid Sample Preparation Market
  • Table 3: Cost of Automated Workstations
目次
Product Code: BHP1345SA

“Global Nucleic Acid Sample Preparation Market to Reach $11,200.5 Million by 2032.”

Overview

The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032. The growth in the global nucleic acid sample preparation market is expected to be driven by the increased use of nucleic acid molecules in several therapeutic areas. In addition, the increased demand for downstream applications such as next-generation sequencing (NGS) and others and the advancement in nucleic acid extraction/isolation techniques have driven the growth of the nucleic acid sample preparation market.

Market Lifecycle Stage

The global nucleic acid sample preparation market is in progressing phase. To meet the growing need for timely diagnostic information and targeted patient treatment, several molecular procedures, including automated nucleic acid sample preparation workstations, have been developed. In addition, sample preparation is essential in precision medicine because it assures the safe and successful use of tailored therapies. The market offers a range of universal products with varied maximum throughputs, innovations, time durations, and other qualities, and companies are searching for innovative methods to distinguish themselves. Additionally, manufacturers began to produce application-specific nucleic acid purification devices and liquid handlers in recent years.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Impact of COVID-19

In December 2019, Wuhan, a city in the Hubei region of China, was the site of the first detection of the COVID-19 outbreak. Following the classification of COVID-19 as novel pneumonia due to a cluster of unexplained pneumonia cases, efforts to pinpoint the culprit causing the outbreak and outline its genomic sequence got underway right once. The virus has already spread to every country on the globe, and researchers, governments, and business leaders are working to find answers to the crisis at a scale and speed that has never been seen. Testing for SARS-CoV-2 in the populace is one of the main steps that has been put into place globally, among many other measures used to stop the spread of the disease. The most crucial benefit of testing is that it offers evidence of illness, enabling individuals and those they have come into contact with to take the required precautions, including quarantining, to minimize community exposure.

Although sample preparation is a technology that is utilized by innumerable laboratories all over the world to examine the genetic makeup of all living things, its application in the diagnosis of infectious diseases is now very limited. In comparison to data obtained through standard testing methods, information obtained through sample preparation using NGS technology, which determines the pathogen's genome sequence, yields a much larger body of knowledge. This knowledge can be used to develop therapeutics and vaccines, track changes in the virus as it spreads through the population, and gain a deeper understanding of patterns of transmission across time and space.

Public health experts needed to comprehend the distribution in the community in addition to the information that sequencing may provide regarding disease transmission. Through data obtained from viral sequencing, National Public Health Laboratory (NPHL) can monitor the emergence and introduction of novel variants like Omicron and put the proper public health countermeasures in place for a population or affected area. By using the NGS technology in sample preparation, researchers were able to help the scientific community to get a deeper comprehension of the alterations that may affect the pathogenicity, infectivity, and transmission of viruses. The following figure shows the workflow of detecting viruses using sample preparation.

Market Segmentation:

Segmentation 1: by Product

  • Systems
  • Consumables
  • Accessories and Components

Based on product, the consumables segment in the global nucleic acid sample preparation market dominated in FY2021. This was due to the increase in the adoption of kits and reagents in this market.

Segmentation 2: by Workflow

  • Sample Extraction/Isolation
  • Sample Quantification
  • Quality Control
  • Fragmentation
  • Target Enrichment
  • Library Quantification
  • Pooling

Based on the workflow, the global nucleic acid sample preparation market was dominated by sample extraction/isolation in FY2021. The high share associated with sample extraction/isolation in the nucleic acid sample preparation ecosystem is majorly attributed to the growing prevalence of oncology medical conditions and rising emphasis on research procedures.

Segmentation 3: by Technology

  • Spin-Column Based Technology
  • Magnetic-Bead Based Technology
  • Other Technologies

Based on technology, the spin column-based technology segment accounted for the largest share of the global nucleic acid sample preparation in FY2021. The large share of this segment can be attributed to the increasing adoption of global nucleic acid sample preparation products, the growing demand to perform rapid and efficient extraction, and the rising need to reduce the sample-to-sample variation arising from the manual process.

Segmentation 4: by Therapeutic Area

  • Oncology
  • Human Genetics/Population Genetics
  • Infectious Disease
  • Others

Based on therapeutic area, the global nucleic acid sample preparation market was dominated by the oncology segment in FY2021, owing to an increase in cancer cases. Sample preparation can make a big difference in the field of oncology because it offers a number of benefits in terms of sensitivity, specificity, and outcomes.

Segmentation 5: by Application

  • Genomics
  • Proteomics
  • Other Applications

Based on application, the global nucleic acid sample preparation market was dominated by the genomics segment in FY2021. The term next-generation sequencing (NGS) refers to novel DNA sequencing methods that offer high speed and throughput and may generate a large number of sequences with a wide range of potential uses in research and diagnostic contexts.

Segmentation 6: by End User

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Other End Users

As of 2021, the global nucleic acid sample preparation market (by end user) was dominated by academic and research institutions. Academic institutions contributions to the nucleic acid sample preparation market are quite advantageous. Variable kits and instruments are typically employed in research settings to evaluate possible medical and diagnostic uses.

Segmentation 7: by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Rest-of-the-World

In 2021, the North America nucleic acid sample preparation market dominated the global market with a 46.99% market share, and it is expected to hold its dominance throughout the forecast period 2022-2032. However, the Asia-Pacific (APAC) region, constituting several emerging economies, is expected to register the highest CAGR of 12.01% during the forecast period 2022-2032.

Recent Developments in the Global Nucleic Acid Sample Preparation Market

  • In June 2022, Hamilton Company. And Bionano Genomics created a Long String VANTAGE, a brand-new DNA extraction automation product. Ultra-high molecular weight (UHMW) DNA can be extracted with the instrument and used for optical genome mapping (OGM). As a requirement for the sample preparation workflow at Bionano Genomics, high-quality and quantity UHMW DNA extraction is required.
  • In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.
  • In June 2021, Agilent Technologies, Inc. launched the SureSelect Human All Exon V8. This new exome design offers thorough content and current coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which is neglected by competing exomes. The new design offers content flexibility to satisfy the demands of customers in three options, i.e., standard exome sequencing (Exome v8), translational research (v8 UTR Plus), and clinical research sequencing (v8 Clinical Plus).
  • In August 2022, the introduction of the QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, both of which have set new benchmarks in sample preparation for determining their nucleic acid sequences, allowed QIAGEN N.V. to announce the extension of its next-generation sequencing (NGS) portfolio. The time required for library preparation of DNA samples by researchers is cut in half to six hours due to the QIAseq Targeted DNA Pro Panels' enhanced chemistry.

Demand - Drivers and Limitations

The following are the demand drivers for the global nucleic acid sample preparation market:

  • Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
  • Advancement in the Nucleic Acid Extraction/Isolation Techniques
  • Advantages of Automated Sample Preparation Workstations
  • Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)

The market is expected to face some limitations due to the following challenges:

  • High Cost of Automated Workstations
  • Rigid Regulatory Standards

How can this report add value to an organization?

  • Workflow/Innovation Strategy: The nucleic sample preparation market (workflow) has been segmented into seven sub-segments, namely, sample extraction/isolation, sample quantification, quality control (QC), fragmentation, library quantification, target enrichment, and pooling. Moreover, the study provides the reader with a detailed understanding of the different applications of sample preparation in genomics and proteomics.
  • Growth/Marketing Strategy: Nucleic acid sample preparation is being used for genomics, proteomics, and other applications. Various companies are providing consumables and systems aid in the diagnosis of various therapeutic areas, which is also the key strategy for market players to excel in the current nucleic acid sample preparation market.
  • Competitive Strategy: Key players in the global nucleic acid sample preparation market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global nucleic acid sample preparation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The emergence of modern technology with automated systems and ways to acquire high-quality nucleic acid has facilitated the extraction, isolation, purification, and other processes. Increased demand for high-quality reagents, kits, and related items has resulted from advancements in the nucleic acid sample preparation procedure. Various researchers and manufacturers have developed automated resources to generate high-quality items in quick turnaround periods. High throughput and sophisticated sample preparation technology, as well as collaborations developed with key research institutions throughout the world to improve sampling methodology, are expected to fuel market expansion during the forecast period.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • BGI Group (MGI Tech Co., Ltd.)
  • BIONEER CORPORATION.
  • Blue-Ray Biotech Corp.
  • Danaher. (Beckman Coulter, Inc.)
  • Endress+Hauser Group Services AG (Analytik Jena GmbH)
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Norgen Biotek Corp.
  • OPENTRONS
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN
  • Sansure Biotech Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Table of Contents

1 Market

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion Criteria
  • 1.2 Market Scope
    • 1.2.1 Scope of the Study
    • 1.2.2 Key Questions Answered in the Report
  • 1.3 Research Methodology
    • 1.3.1 Global Nucleic Acid Sample Preparation Market: Research Methodology
    • 1.3.2 Data Sources
      • 1.3.2.1 Primary Data Sources
      • 1.3.2.2 Secondary Data Sources
    • 1.3.3 Market Estimation Model
    • 1.3.4 Criteria for Company Profiling
  • 1.4 Market Overview
    • 1.4.1 Market Definition
    • 1.4.2 Market Footprint and Growth Potential, $Million, 2021-2032
  • 1.5 Addressable Market Size and Growth Potential ($Million), 2021-2032
    • 1.5.1 North America
    • 1.5.2 Europe
    • 1.5.3 Asia-Pacific
    • 1.5.4 Latin America
    • 1.5.5 Rest-of-the-World
  • 1.6 Industry Participants Landscape

2 Global Nucleic Acid Sample Preparation Market, Industry Analysis

  • 2.1 Industry Insights
    • 2.1.1 Legal Requirements and Framework in the U.S.
      • 2.1.1.1 U.S. FDA Published Guidance
      • 2.1.1.2 U.S. FDA Regulations
    • 2.1.2 Legal Requirements and Framework in Europe
    • 2.1.3 Legal Requirements and Framework in Asia-Pacific
      • 2.1.3.1 China
      • 2.1.3.2 Japan
        • 2.1.3.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
      • 2.1.3.3 India
  • 2.2 Patent Analysis
    • 2.2.1 Patent Filing Trend
    • 2.2.2 Patent Analysis (by Year)
    • 2.2.3 Patent Analysis (by Country)
    • 2.2.4 Patent Analysis (by Region)
  • 2.3 Impact of COVID-19 on the Global Nucleic Acid Sample Preparation Market

3 Global Nucleic Acid Sample Preparation Market: Market Dynamics

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
    • 3.2.2 Advancement in the Nucleic Acid Extraction/Isolation Techniques
    • 3.2.3 Advantages of Automated Sample Preparation Workstations
    • 3.2.4 Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
  • 3.3 Market Restraints
    • 3.3.1 High Cost of Automated Workstations
    • 3.3.2 Rigid Regulatory Standards
  • 3.4 Market Opportunities
    • 3.4.1 Technological Advancements in Automated Sample Preparation Workstations
    • 3.4.2 Nucleic Acid Molecules for Biobanking in Healthcare
    • 3.4.3 Growth in Emerging Nations

4 Competitive Landscape

  • 4.1 Overview
  • 4.2 Corporate Strategies
    • 4.2.1 Mergers and Acquisitions
    • 4.2.2 Synergistic Activities
    • 4.2.3 Business Expansions
  • 4.3 Business Strategies
    • 4.3.1 Product Launches
  • 4.4 Market Share Analysis

5 Global Nucleic Acid Sample Preparation Market, by Product ($Million), 2021-2032

  • 5.1 Overview
  • 5.2 Consumables
    • 5.2.1 Sample Extraction and Isolation Kits
    • 5.2.2 Sample Purification Kits
    • 5.2.3 Library Preparation Kits
    • 5.2.4 Clean-Up and Selection Kits
    • 5.2.5 Target Enrichment Kits
    • 5.2.6 Microbiome DNA Enrichment
  • 5.3 Systems
    • 5.3.1 Liquid Handling Systems
    • 5.3.2 Nucleic Acid Extraction/Isolation Systems
    • 5.3.3 Fragment Analyzers
    • 5.3.4 Other Sample Preparation Systems
  • 5.4 Accessories and Components

6 Global Nucleic Acid Sample Preparation Market, by Workflow ($Million), 2021-2032

  • 6.1 Overview
  • 6.2 Sample Extraction/Isolation
  • 6.3 Sample Quantification
  • 6.4 Quality Control (QC)
  • 6.5 Fragmentation
  • 6.6 Target Enrichment
  • 6.7 Library Quantification
  • 6.8 Pooling

7 Global Nucleic Acid Sample Preparation Market, by Technology ($Million), 2021-2032

  • 7.1 Overview
  • 7.2 Spin-Column Based Technology
  • 7.3 Magnetic-Bead Based Technology
  • 7.4 Other Technologies

8 Global Nucleic Acid Sample Preparation Market, by Therapeutic Area ($Million), 2021-2032

  • 8.1 Overview
  • 8.2 Oncology
  • 8.3 Infectious Disease
  • 8.4 Human Genetics/Population Genetics
  • 8.5 Others

9 Global Nucleic Acid Sample Preparation Market, by Application ($Million), 2021-2032

  • 9.1 Overview
  • 9.2 Genomics
  • 9.3 Proteomics
  • 9.4 Other Applications

10 Global Nucleic Acid Sample Preparation Market, by End User ($Million), 2021-2032

  • 10.1 Overview
  • 10.2 Academic and Research Institutions
  • 10.3 Pharmaceutical and Biotechnology Companies
  • 10.4 Clinical and Diagnostic Laboratories
  • 10.5 Other End Users

11 Global Nucleic Acid Sample Preparation Market, by Region ($Million), 2021-2032

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 France
    • 11.3.3 U.K.
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Rest-of-Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest-of-Asia-Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest-of-Latin America
  • 11.6 Rest-of-the-World

12 Company Profiles

  • 12.1 Overview
  • 12.2 Agilent Technologies, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 12.2.3 Key Competitors of the Company
    • 12.2.4 Business Strategies
    • 12.2.5 Financials
    • 12.2.6 Analyst Perspective
  • 12.3 Aurora Biomed Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of Aurora Biomed Inc. in the Global Nucleic Acid Sample Preparation Market
    • 12.3.3 Key Customers of the Company
    • 12.3.4 Key Competitors of the Company
    • 12.3.5 Analyst Perspective
  • 12.4 BGI Group (MGI Tech Co., Ltd.)
    • 12.4.1 Company Overview
    • 12.4.2 Role of BGI Group (MGI Tech Co., Ltd.) in the Global Nucleic Acid Sample Preparation Market
    • 12.4.3 Key Competitors of the Company
    • 12.4.4 Business Strategies
    • 12.4.5 Analyst Perspective
  • 12.5 BIONEER CORPORATION.
    • 12.5.1 Company Overview
    • 12.5.2 Role of BIONEER CORPORATION. in the Global Nucleic Acid Sample Preparation Market
    • 12.5.3 Key Competitors of the Company
    • 12.5.4 Analyst Perspective
  • 12.6 Blue-Ray Biotech Corp.
    • 12.6.1 Company Overview
    • 12.6.2 Role of Blue-Ray Biotech Corp. in the Global Nucleic Acid Sample Preparation Market
    • 12.6.3 Key Competitors of the Company
    • 12.6.4 Business Strategies
    • 12.6.5 Analyst Perspective
  • 12.7 Danaher. (Beckman Coulter, Inc.)
    • 12.7.1 Company Overview
    • 12.7.2 Role of Danaher. (Beckman Coulter, Inc.) in the Global Nucleic Acid Sample Preparation Market
    • 12.7.3 Key Competitors of the Company
    • 12.7.4 Corporate Strategies
    • 12.7.5 Business Strategies
    • 12.7.6 Financials
    • 12.7.7 Key Insights about the Financial Health of the Company
    • 12.7.8 Analyst Perspective
  • 12.8 Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 12.8.1 Company Overview
    • 12.8.2 Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
    • 12.8.3 Key Customers of the Company
    • 12.8.4 Key Competitors of the Company
    • 12.8.5 Business Strategies
    • 12.8.6 Financials
    • 12.8.7 Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
    • 12.8.8 Key Insights about the Financial Health of the Company
    • 12.8.9 Analyst Perspective
  • 12.9 Eppendorf SE
    • 12.9.1 Company Overview
    • 12.9.2 Role of Eppendorf SE in the Global Nucleic Acid Sample Preparation Market
    • 12.9.3 Key Competitors of the Company
    • 12.9.4 Financials
    • 12.9.5 Key Insights about the Financial Health of the Company
    • 12.9.6 Analyst Perspective
  • 12.1 F. Hoffmann-La Roche Ltd
    • 12.10.1 Company Overview
    • 12.10.2 Role of F. Hoffmann-La Roche Ltd in the Global Nucleic Acid Sample Preparation Market
    • 12.10.3 Key Competitors of the Company
    • 12.10.4 Business Strategies
    • 12.10.5 Financials
    • 12.10.6 Key Insights about the Financial Health of the Company
    • 12.10.7 Analyst Perspective
  • 12.11 Illumina, Inc.
    • 12.11.1 Company Overview
    • 12.11.2 Role of Illumina, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 12.11.3 Key Customers of the Company
    • 12.11.4 Key Competitors of the Company
    • 12.11.5 Financials
    • 12.11.6 Key Insights about the Financial Health of the Company
    • 12.11.7 Analyst Perspective
  • 12.12 Merck KGaA
    • 12.12.1 Company Overview
    • 12.12.2 Role of Merck KGaA in the Global Nucleic Acid Sample Preparation Market
    • 12.12.3 Key Competitors of the Company
    • 12.12.4 Financials
    • 12.12.5 Key Insights about the Financial Health of the Company
    • 12.12.6 Analyst Perspective
  • 12.13 Norgen Biotek Corp.
    • 12.13.1 Company Overview
    • 12.13.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Sample Preparation Market
    • 12.13.3 Key Competitors of the Company
    • 12.13.4 Analyst Perspective
  • 12.14 OPENTRONS
    • 12.14.1 Company Overview
    • 12.14.2 Role of OPENTRONS in the Global Nucleic Acid Sample Preparation Market
    • 12.14.3 Key Customers of the Company
    • 12.14.4 Key Competitors of the Company
    • 12.14.5 Corporate Strategies
    • 12.14.6 Analyst Perspective
  • 12.15 PerkinElmer Inc.
    • 12.15.1 Company Overview
    • 12.15.2 Role of PerkinElmer Inc. in the Global Nucleic Acid Sample Preparation Market
    • 12.15.3 Key Customers of the Company
    • 12.15.4 Key Competitors of the Company
    • 12.15.5 Business Strategies
    • 12.15.6 Financials
    • 12.15.7 Key Insights about the Financial Health of the Company
    • 12.15.8 Analyst Perspective
  • 12.16 Promega Corporation
    • 12.16.1 Company Overview
    • 12.16.2 Role of Promega Corporation in the Global Nucleic Acid Sample Preparation Market
    • 12.16.3 Key Customers of the Company
    • 12.16.4 Key Competitors of the Company
    • 12.16.5 Business Strategies
    • 12.16.6 Analyst Perspective
  • 12.17 QIAGEN
    • 12.17.1 Company Overview
    • 12.17.2 Role of QIAGEN in the Global Nucleic Acid Sample Preparation Market
    • 12.17.3 Key Customers of the Company
    • 12.17.4 Key Competitors of the Company
    • 12.17.5 Business Strategies
    • 12.17.6 Financials
    • 12.17.7 Key Insights about the Financial Health of the Company
    • 12.17.8 Analyst Perspective
  • 12.18 Sansure Biotech Inc.
    • 12.18.1 Company Overview
    • 12.18.2 Role of Sansure Biotech Inc. in the Global Nucleic Acid Sample Preparation Market
    • 12.18.3 Key Competitors of the Company
    • 12.18.4 Financials
    • 12.18.5 Key Insights about the Financial Health of the Company
    • 12.18.6 Analyst Perspective
  • 12.19 Tecan Trading AG
    • 12.19.1 Company Overview
    • 12.19.2 Role of Tecan Trading AG in the Global Nucleic Acid Sample Preparation Market
    • 12.19.3 Key Customers of the Company
    • 12.19.4 Key Competitors of the Company
    • 12.19.5 Financials
    • 12.19.6 Key Insights about the Financial Health of the Company
    • 12.19.7 Analyst Perspective
  • 12.2 Thermo Fisher Scientific Inc.
    • 12.20.1 Company Overview
    • 12.20.2 Role of Thermo Fisher Scientific Inc. in the Global Nucleic Acid Sample Preparation Market
    • 12.20.3 Key Customers of the Company
    • 12.20.4 Key Competitors of the Company
    • 12.20.5 Business Strategies
    • 12.20.6 Financials
    • 12.20.7 Key Insights about the Financial Health of the Company
    • 12.20.8 Analyst Perspective
  • 12.21 Emerging Companies
    • 12.21.1 BioDynami
    • 12.21.2 ELEMENT BIOSCIENCES
    • 12.21.3 Miroculus
    • 12.21.4 SPT Labtech Ltd